Pixium Vision
A bioelectronics company that developed bionic vision systems for retinal diseases.
ALPIX | PA
Overview
Corporate Details
- ISIN(s):
- FR0011950641 (+1 more)
- LEI:
- 96950046OPLRLKKEOO08
- Country:
- France
- Address:
- 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
- Website:
- https://www.pixium-vision.com/
- Sector:
- Manufacturing
Description
Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-08 07:00 |
Pixium Vision annonce avoir reçu 1,8 M d’euros de Crédit d’Impôt Recherche acco…
|
French | 290.6 KB | ||
| 2023-06-08 07:00 |
Pixium Vision announces receipt of € 1.8 million from the French Government as …
|
English | 284.4 KB | ||
| 2023-05-24 19:00 |
Assemblée Générale Annuelle du 13 juin 2023 : Modalités de mise à disposition d…
|
English | 124.4 KB | ||
| 2023-05-24 19:00 |
Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory docu…
|
English | 124.4 KB | ||
| 2023-05-10 19:00 |
Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023
|
English | 120.9 KB | ||
| 2023-05-10 19:00 |
Pixium Vision convoque son Assemblée Générale Annuelle le 13 juin 2023
|
French | 121.3 KB | ||
| 2023-04-25 19:00 |
Pixium Vision announces the availability of its annual report for the financial…
|
English | 119.2 KB | ||
| 2023-04-25 19:00 |
Pixium Vision annonce la mise à disposition de son rapport annuel 2022
|
French | 120.6 KB | ||
| 2023-04-21 07:00 |
Pixium Vision annonce ses comptes consolidés pour l’exercice 2022 et sa positio…
|
French | 226.2 KB | ||
| 2023-04-21 07:00 |
Pixium Vision announces its consolidated financial statements for the financial…
|
English | 154.4 KB | ||
| 2023-04-03 07:00 |
Communication faisant suite à l’annonce de l’obtention du statut Breakthrough D…
|
French | 179.6 KB | ||
| 2023-04-03 07:00 |
Communication following the announcement of FDA Breakthrough Device Designation…
|
English | 174.6 KB | ||
| 2023-03-31 07:00 |
Breakthrough Device Designation ENG
|
English | 230.6 KB | ||
| 2023-03-31 07:00 |
Breakthrough Device Designation FR
|
French | 208.1 KB | ||
| 2023-03-17 07:00 |
Réduction du capital social motivée par des pertes par réduction de la valeur n…
|
French | 169.9 KB |
Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pixium Vision
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pixium Vision via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Sell | 42,681 | 16,517.55 EUR |
| 2024-01-09 | N/A | Other | Sell | 80,325 | 45,608.54 EUR |
| 2024-01-08 | N/A | Other | Sell | 110,740 | 69,732.98 EUR |
| 2023-12-04 | N/A | Other | Sell | 665 | 60.98 EUR |